melatonin has been researched along with Child Mental Disorders in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We will include randomised clinical trials comparing melatonin versus placebo or no intervention for sleep disorders in children with neurodevelopmental disorders." | 9.51 | Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials. ( Faltermeier, P; Gluud, C; Hermann, R; Horowitz, M; Jakobsen, JC; Juul, S; Jørgensen, CK; Moncrieff, J, 2022) |
| "Clinical evidence is required about the long-term efficacy and safety of melatonin treatment for sleep problems in children with neurodevelopmental disorders (NDDs) who underwent adequate sleep hygiene interventions." | 9.34 | Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders. ( Hamada, I; Hayashi, M; Ishikawa, Y; Mishima, K; Nagamitsu, S; Sugioka, H; Takahashi, H; Yamashita, Y; Yotsuya, O; Yuge, K, 2020) |
| "To determine the efficacy and safety of melatonin as therapy for sleep problems in children with neurodevelopmental disorders." | 8.98 | Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. ( Abdelgadir, IS; Akobeng, AK; Gordon, MA, 2018) |
| "7 years) with neurodevelopmental disorders (n = 29: intellectual disability; n = 9: autism spectrum disorder; n = 7: attention-deficit/hyperactivity disorder) and sleep disturbances, treated with melatonin (mean duration: 326 days) with doses increased according to response." | 7.81 | Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study. ( Ayyash, HF; Cortese, S; Morton, R; Preece, P, 2015) |
| " We will include randomised clinical trials comparing melatonin versus placebo or no intervention for sleep disorders in children with neurodevelopmental disorders." | 5.51 | Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials. ( Faltermeier, P; Gluud, C; Hermann, R; Horowitz, M; Jakobsen, JC; Juul, S; Jørgensen, CK; Moncrieff, J, 2022) |
| "Children with neurodevelopmental disorders are at risk of sleep problems, typically difficulty getting to sleep, sleep/wake rhythm disturbances and reduced duration of sleep (insomnia)." | 5.42 | Melatonin for sleep problems in children with neurodevelopmental disorders. ( , 2015) |
| "Clinical evidence is required about the long-term efficacy and safety of melatonin treatment for sleep problems in children with neurodevelopmental disorders (NDDs) who underwent adequate sleep hygiene interventions." | 5.34 | Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders. ( Hamada, I; Hayashi, M; Ishikawa, Y; Mishima, K; Nagamitsu, S; Sugioka, H; Takahashi, H; Yamashita, Y; Yotsuya, O; Yuge, K, 2020) |
| "To determine the efficacy and safety of melatonin as therapy for sleep problems in children with neurodevelopmental disorders." | 4.98 | Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. ( Abdelgadir, IS; Akobeng, AK; Gordon, MA, 2018) |
| "7 years) with neurodevelopmental disorders (n = 29: intellectual disability; n = 9: autism spectrum disorder; n = 7: attention-deficit/hyperactivity disorder) and sleep disturbances, treated with melatonin (mean duration: 326 days) with doses increased according to response." | 3.81 | Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study. ( Ayyash, HF; Cortese, S; Morton, R; Preece, P, 2015) |
| " However, there is still uncertainty concerning dosing regimens and a lack of other data." | 2.61 | Pediatric sleep disturbances and treatment with melatonin. ( Argentiero, A; D'Alonzo, R; Di Genova, L; Esposito, S; Fattorusso, A; Laino, D; Mencarelli, A; Mencaroni, E, 2019) |
| "Children with neurodevelopmental disorders are at risk of sleep problems, typically difficulty getting to sleep, sleep/wake rhythm disturbances and reduced duration of sleep (insomnia)." | 1.42 | Melatonin for sleep problems in children with neurodevelopmental disorders. ( , 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Salanitro, M | 1 |
| Wrigley, T | 1 |
| Ghabra, H | 1 |
| de Haan, E | 1 |
| Hill, CM | 1 |
| Solmi, M | 1 |
| Cortese, S | 2 |
| Dack, R | 1 |
| Garstang, JJ | 1 |
| Jørgensen, CK | 3 |
| Hermann, R | 3 |
| Juul, S | 3 |
| Faltermeier, P | 3 |
| Horowitz, M | 3 |
| Moncrieff, J | 3 |
| Gluud, C | 3 |
| Jakobsen, JC | 3 |
| Bruni, O | 1 |
| Angriman, M | 1 |
| Melegari, MG | 1 |
| Ferri, R | 1 |
| Yuge, K | 1 |
| Nagamitsu, S | 1 |
| Ishikawa, Y | 1 |
| Hamada, I | 1 |
| Takahashi, H | 1 |
| Sugioka, H | 1 |
| Yotsuya, O | 1 |
| Mishima, K | 1 |
| Hayashi, M | 1 |
| Yamashita, Y | 1 |
| Woodford, EC | 1 |
| McLay, L | 1 |
| France, KG | 1 |
| Blampied, NM | 1 |
| Gibbs, R | 1 |
| Swan, CE | 1 |
| Eggleston, M | 1 |
| Abdelgadir, IS | 1 |
| Gordon, MA | 1 |
| Akobeng, AK | 1 |
| Smith, ACM | 1 |
| Morse, RS | 1 |
| Introne, W | 1 |
| Duncan, WC | 1 |
| Esposito, S | 1 |
| Laino, D | 1 |
| D'Alonzo, R | 1 |
| Mencarelli, A | 1 |
| Di Genova, L | 1 |
| Fattorusso, A | 1 |
| Argentiero, A | 1 |
| Mencaroni, E | 1 |
| Ayyash, HF | 1 |
| Preece, P | 1 |
| Morton, R | 1 |
| Waldron, AY | 1 |
| Spark, MJ | 1 |
| Dennis, CM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders -[NCT02757066] | Phase 2/Phase 3 | 196 participants (Actual) | Interventional | 2016-06-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for melatonin and Child Mental Disorders
| Article | Year |
|---|---|
Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
Topics: Adolescent; Child; Humans; Melatonin; Neurodevelopmental Disorders; Sleep; Sleep Wake Disorders | 2022 |
Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders.
Topics: Antidepressive Agents; Antipsychotic Agents; Child; Dietary Supplements; Humans; Hypnotics and Sedat | 2019 |
Endogenous melatonin and sleep in individuals with Rare Genetic Neurodevelopmental Disorders (RGND): A systematic review.
Topics: Humans; Melatonin; Neurodevelopmental Disorders; Sleep; Sleep Wake Disorders; Smith-Magenis Syndrome | 2021 |
Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis.
Topics: Central Nervous System Depressants; Child; Humans; Melatonin; Models, Statistical; Neurodevelopmenta | 2018 |
Pediatric sleep disturbances and treatment with melatonin.
Topics: Child; Child Behavior; Humans; Melatonin; Mental Disorders; Neurodevelopmental Disorders; Sleep Wake | 2019 |
2 trials available for melatonin and Child Mental Disorders
5 other studies available for melatonin and Child Mental Disorders
| Article | Year |
|---|---|
Use of melatonin: a single-centre audit.
Topics: Adolescent; Autism Spectrum Disorder; Child; Humans; Melatonin; Neurodevelopmental Disorders; Sleep | 2022 |
Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.
Topics: Adolescent; Adult; Body Temperature; Child; Chromosomes, Human, Pair 17; Circadian Clocks; Circadian | 2019 |
Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.
Topics: Analysis of Variance; Central Nervous System Depressants; Child; Child, Preschool; Dose-Response Rel | 2015 |
Melatonin for sleep problems in children with neurodevelopmental disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Humans; Hypnotics an | 2015 |
The Use of Melatonin by Children: Parents' Perspectives.
Topics: Adolescent; Attitude to Health; Australia; Central Nervous System Depressants; Child; Child, Prescho | 2016 |